Steven J. Greco PhD
Chief Science Officer
With nearly two decades of work in stem cell biology, regenerative and translational medicine, Dr. Greco serves as Chief Science Officer for Okyanos Global Health. Author on more than 55 research publications, Dr. Greco directs translational research at Okyanos Innovation Center, coordinating with Okyanos Therapeutics companies including Rejenevie™ Therapetics. He received both his PhD in stem cell biology and MS in biomedical sciences from Rutgers University and his BA from Cornell University.
Khady Guiro, PhD
Dr. Guiro brings a diverse background in biomedical engineering and regenerative medicine to her position as Lead Scientist for the Okyanos Innovation Center. Her current research is in age-related diseases and hematopoietic stem cells (HSCs), where she has been lead scientists on ARMT’s first in man treatment for anti-aging. Dr. Guiro holds a patent on a 3D in vitro model for breast cancer dormancy. Dr. Guiro received her PhD in Biomedical Engineering and Biomedical Sciences from New Jersey Institute of Technology and Rutgers New Jersey Medical School.
Director of Operational Management
As Director of Operational Management of the Okyanos Innovation Center, Ben Chlebina manages the operational, strategic planning, financial and marketing efforts of the Okyanos Innovation Center management to optimize growth and maximize value. Passionate about regenerative medicine and translational research, Mr. Chlebina joined the Okyanos Innovation Center with a career focused on biomedical research and drug development.
Lab & Environmental Compliance Manager
Nicole Bradley, PhD
Senior Laboratory Technician
Quality Assurance Specialist
& Lab Associate